Grunenthal Acquires Averitas Pharma and Establishes Commercial...
AACHEN, Germany and MORRISTOWN, New Jersey, November 14, 2018 /PRNewswire-AsiaNet/ -- Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsa...
Read more https://view-release/?pr-id=76292